Differential effect of tacrine and physostigmine on the secretion of the β-amyloid precursor protein in cell lines

Journal of Molecular Neuroscience

Volumn 7, Issue 1, 1996, Pages 41-49

  Lahiri, Debomoy K ^a   Farlow, Martin R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cholinergic agents; Cholinesterase inhibitors; Lysosomes; amyloid precursor proteins

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ARECOLINE; ATROPINE; CALCIMYCIN; CARBACHOL; CHOLINESTERASE INHIBITOR; ENZYME INHIBITOR; IONOPHORE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; PHYSOSTIGMINE; STAUROSPORINE; TACRINE;

ANIMAL; ARTICLE; ASTROCYTE; CELL STRAIN; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; HELA CELL; HUMAN; NEUROBLASTOMA; RAT; SECRETION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ARECOLINE; ASTROCYTES; ATROPINE; CALCIMYCIN; CARBACHOL; CHOLINESTERASE INHIBITORS; ENZYME INHIBITORS; HELA CELLS; HUMANS; IONOPHORES; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEUROBLASTOMA; PC12 CELLS; PHYSOSTIGMINE; RATS; STAUROSPORINE; TACRINE;

EID: 0030092766     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02736847     Document Type: Article

References (20)

1. Becker R. and Giacobini E. (1994) Cholinergic Basis of Alzheimer's Disease. Birkhauser, Boston, MA.
2. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and Greengard P. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. USA 89, 10,075-10,078.
4. Checler F. (1995) Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
5. Dell'Antone P., Bragadin M., and Zatta P. (1995) Anticholinesterase drugs: tacrine but not physostigmine, accumulates in acidic compartments of the cells. Biochim. Biophys. Acta 1270, 137-141.
6. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248, 1122-1124.
7. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B. D., and Younkin S. G. (1992) Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255, 726-728.
8. Farlow M., Gracon S. I., Hershey L. A., Lewis K. W., Sadowsky C. H., and Dolan-Ureno J. (1992) A controlled trial of tacrine in Alzheimer's disease. JAMA 268, 2523-2529.
9. + channels and suppression of neuronal activity by secreted β-amyloid-precursor protein. Nature 379, 74-78.
10. Greig N. H., Pei X.-F., Soncrant T. T., Ingram D. K., and Brossi A. (1995) Phenserine and ring C heteroanalogues: drug candidates for the treatment of Alzheimer's disease. Med. Res. Rev. 15, 3-31.
11. Growdon J. H. (1992) Treatment for Alzheimer's disease? New Eng. J. Med. 327, 1306-1308.
12. Haass C., Koo E. H., Mellon A., Hung A. Y., and Selkoe D. J. (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357, 500-503.
13. Hay R., Caputo J., Chen T. R., Macy M., McClintock P., and Reid Y. (1992) ATCC Collection Catalogue of Cell Lines and Hybridomas, 7th ed., ATCC, Rockville, MD.
14. Hilbich C., Monning U., Grund C., Masters C. L., and Beyreuther K. (1993) Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. J. Biol Chem. 268, 26,571-26,577.
15. John V., Lieberburg I., and Thorsett E. D. (1993) Alzheimer's disease: current therapeutic approaches. Ann. Rep. Med. Chem. 28, 197-206.
16. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grezeschik K. H., Multhaup G., Beyreuther K., and Muller-Hil B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
17. Katzung G. B. (1995) Basic principles: introduction, in Basic and Clinical Pharmacology (Katzung G. B., ed.), Appleton & Lange, Norwalk, CT, pp. 1-8.
18. Kim K. S., Miller D. L., Sapienze B. J., Chang C. J., Grundke-Iqbal I., Currie J. R., and Wisniewski H. M. (1988) Production and characterization of monoclonal antibodies to synthetic cerebral vascular amyloid peptide. Neurosci. Res. Commun. 2, 121-130.
19. Knops J., Lieberburg I., and Sinha S. (1992) Evidence for a nonsecretory, acidic degradation pathway for amyloid precursor protein in 293 cells. J. Biol. Chem. 267, 16,022-16,024.
20. Kuentzel S. L., Ali S. M., Altman R. A., Greenberg B. D., and Raub T. J. (1993) The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295, 367-378.